GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanologica AB (OSTO:NICA) » Definitions » Buyback Yield %

Nanologica AB (OSTO:NICA) Buyback Yield % : -84.30 (As of Apr. 30, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Nanologica AB Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Nanologica AB's current buyback yield was -84.30%.


Nanologica AB Buyback Yield % Historical Data

The historical data trend for Nanologica AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanologica AB Buyback Yield % Chart

Nanologica AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -30.65 -0.89 -22.08 -0.03 -81.77

Nanologica AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.27 -17.10 -42.60 -81.77 -86.57

Competitive Comparison of Nanologica AB's Buyback Yield %

For the Biotechnology subindustry, Nanologica AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanologica AB's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanologica AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Nanologica AB's Buyback Yield % falls into.


;
;

Nanologica AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Nanologica AB's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 131.49) / 160.80974
=-81.77%

Nanologica AB's annualized Buyback Yield for the quarter that ended in Mar. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 99.06) / 114.422315
=-86.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .


Nanologica AB Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Nanologica AB's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanologica AB Business Description

Traded in Other Exchanges
N/A
Address
Forskargatan 20 G, Sodertalje, SWE, SE-151 36
Nanologica AB is engaged in the production and sales of silica-based chromatography products. The company develops and manufactures nanoporous silica particles for life science applications. The company's drug delivery platforms are NLAB Spiro, NLAB Silica, and others, which focus on producing medicines for the benefit of patients. Its geographical segments are China, India, the United States, and the Rest of the world.

Nanologica AB Headlines

No Headlines